|
humans |
56 |
|
animals |
45 |
|
phylogeny |
33 |
|
china - epidemiology |
28 |
|
influenza |
27 |
|
molecular sequence data |
25 |
|
female |
23 |
|
genome, viral |
23 |
|
male |
23 |
|
adult |
22 |
|
hong kong - epidemiology |
22 |
|
poultry - virology |
22 |
|
sequence analysis, dna |
22 |
|
swine |
22 |
|
avian |
21 |
|
reverse transcriptase polymerase chain reaction |
21 |
|
rna, viral - genetics |
21 |
|
birds - virology |
20 |
|
evolution, molecular |
20 |
|
disease outbreaks |
19 |
|
influenza, human - virology |
19 |
|
avian influenza |
17 |
|
china |
17 |
|
genotype |
17 |
|
hong kong |
17 |
|
influenza a virus, h1n1 subtype - immunology |
17 |
|
molecular epidemiology |
17 |
|
swine - virology |
17 |
|
antibodies, viral - blood |
16 |
|
base sequence |
16 |
|
h5n1 |
16 |
|
influenza a |
16 |
|
respiratory system - virology |
16 |
|
amino acid sequence |
15 |
|
cells, cultured |
15 |
|
feces - virology |
15 |
|
influenza a virus, h5n1 subtype - classification - genetics - isolation & purification |
15 |
|
influenza in birds - epidemiology - virology |
15 |
|
time factors |
15 |
|
antigens, viral - analysis |
14 |
|
birds |
14 |
|
blotting, western |
14 |
|
cytokines - metabolism |
14 |
|
disease outbreaks - statistics & numerical data |
14 |
|
genetic variation |
14 |
|
influenza a virus, h5n1 subtype - genetics - immunology |
14 |
|
middle aged |
14 |
|
virulence |
14 |
|
zoonosis |
14 |
|
animals, wild - virology |
13 |
|
cell line |
13 |
|
conjunctiva - virology |
13 |
|
coronavirus - genetics - isolation & purification |
13 |
|
ducks - virology |
13 |
|
human |
13 |
|
influenza a virus, h5n1 subtype - immunology |
13 |
|
astroviridae infections - epidemiology - veterinary - virology |
12 |
|
bronchi - cytology |
12 |
|
coronavirus - classification - genetics - isolation & purification |
12 |
|
cross reactions |
12 |
|
ferrets - virology |
12 |
|
hemagglutinin glycoproteins, influenza virus - genetics |
12 |
|
immunity, innate |
12 |
|
influenza a virus, h1n1 subtype - metabolism |
12 |
|
influenza a virus, h5n1 subtype - classification - genetics |
12 |
|
influenza, human - epidemiology - virology |
12 |
|
receptors, cell surface - metabolism |
12 |
|
serotyping |
12 |
|
adolescent |
11 |
|
cytokines - immunology |
11 |
|
disease outbreaks - prevention & control |
11 |
|
evolution |
11 |
|
influenza in birds - epidemiology - transmission - virology |
11 |
|
influenza, human - epidemiology - transmission - virology |
11 |
|
neutralization tests |
11 |
|
orthomyxoviridae infections - epidemiology - transmission - veterinary - virology |
11 |
|
pathogenesis |
11 |
|
rna, viral - metabolism |
11 |
|
sars |
11 |
|
seasons |
11 |
|
sequence homology, amino acid |
11 |
|
severe acute respiratory syndrome |
11 |
|
severe acute respiratory syndrome - epidemiology - immunology - virology |
11 |
|
species specificity |
11 |
|
viral proteins - genetics |
11 |
|
virus evolution |
11 |
|
adaptor proteins, signal transducing - genetics - immunology - metabolism |
10 |
|
aged |
10 |
|
asia - epidemiology |
10 |
|
biodiversity |
10 |
|
chemicals and cas registry numbers |
10 |
|
coronavirus |
10 |
|
cyclooxygenase 2 - biosynthesis - genetics |
10 |
|
cyclooxygenase 2 inhibitors |
10 |
|
dead-box rna helicases - genetics - immunology - metabolism |
10 |
|
epithelial cells - immunology - metabolism |
10 |
|
genes, viral |
10 |
|
influenza a virus, h1n1 subtype - genetics - growth & development - pathogenicity |
10 |
|
influenza a virus, h1n1 subtype - genetics - immunology |
10 |
|
influenza a virus, h1n2 subtype - genetics - growth & development - pathogenicity |
10 |
|
influenza a virus, h5n1 subtype - genetics - immunology - pathogenicity |
10 |
|
influenza a virus, h5n1 subtype - metabolism |
10 |
|
influenza in birds - enzymology - immunology - virology |
10 |
|
influenza in birds - virology |
10 |
|
influenza, human - enzymology - virology |
10 |
|
influenza, human - immunology - metabolism - virology |
10 |
|
influenza, human - metabolism - transmission |
10 |
|
influenza, human - transmission - virology |
10 |
|
interferon regulatory factor-3 - metabolism |
10 |
|
janus kinases - immunology |
10 |
|
macrophages - immunology - metabolism |
10 |
|
neuraminidase - genetics |
10 |
|
nf-kappa b - metabolism |
10 |
|
organ culture techniques |
10 |
|
p38 mitogen-activated protein kinases - metabolism |
10 |
|
paracrine communication - immunology |
10 |
|
polymerase chain reaction |
10 |
|
prevalence |
10 |
|
pulmonary alveoli - immunology - metabolism |
10 |
|
reassortant viruses - isolation & purification |
10 |
|
receptor, interferon alpha-beta - immunology |
10 |
|
respiratory mucosa - virology |
10 |
|
rna, small interfering - genetics |
10 |
|
sars virus - genetics - isolation & purification |
10 |
|
sars virus - immunology |
10 |
|
seroepidemiologic studies |
10 |
|
severe acute respiratory syndrome - virology |
10 |
|
signal transduction |
10 |
|
toll-like receptor 3 - metabolism |
10 |
|
up-regulation |
10 |
|
vietnam - epidemiology |
10 |
|
viral tropism |
10 |
|
virus attachment |
10 |
|
acute lung injury |
9 |
|
alveolar fluid clearance |
9 |
|
bayes theorem |
9 |
|
blood donors |
9 |
|
chiroptera - classification - virology |
9 |
|
chiroptera - virology |
9 |
|
coronavirus - classification - genetics |
9 |
|
cross infection - epidemiology - immunology |
9 |
|
cross protection |
9 |
|
enzyme-linked immunosorbent assay |
9 |
|
genetics |
9 |
|
h1n1 |
9 |
|
history, 21st century |
9 |
|
immunoglobulin g - analysis - immunology |
9 |
|
influenza a virus, h1n1 subtype - classification - genetics - isolation and purification - physiology |
9 |
|
influenza a virus, h1n1 subtype - genetics - pathogenicity |
9 |
|
influenza a virus, h1n1 subtype - physiology |
9 |
|
influenza virus |
9 |
|
influenza, human - diagnosis - virology |
9 |
|
influenza, human - epidemiology - immunology - virology |
9 |
|
influenza, human - epidemiology - prevention & control - transmission - virology |
9 |
|
mamastrovirus - classification - genetics - isolation & purification |
9 |
|
membrane glycoproteins - analysis |
9 |
|
mesenchymal stromal cells |
9 |
|
models, genetic |
9 |
|
molecular sequence numbers |
9 |
|
nucleocapsid proteins - genetics - immunology |
9 |
|
pandemics |
9 |
|
pneumonia, viral - epidemiology - immunology - virology |
9 |
|
pneumonia, viral - virology |
9 |
|
poultry |
9 |
|
reassortant viruses - classification - genetics - isolation and purification |
9 |
|
recombinant proteins - analysis - immunology |
9 |
|
sars virus - genetics |
9 |
|
sars virus - isolation & purification |
9 |
|
swine - blood - virology |
9 |
|
swine diseases - blood - epidemiology - transmission - virology |
9 |
|
t-lymphocytes, cytotoxic - immunology |
9 |
|
viral envelope proteins - analysis |
9 |
|
virus replication |
9 |
|
2009 pandemic h1n1 influenza virus |
8 |
|
abattoirs |
8 |
|
adaptation, biological |
8 |
|
amino acid substitution |
8 |
|
asia, southeastern |
8 |
|
biology |
8 |
|
biotechnology technology: comprehensive works medical sciences chemistry |
8 |
|
bronchi - immunology - pathology |
8 |
|
canada - epidemiology |
8 |
|
chemokines |
8 |
|
chicken |
8 |
|
conjunctiva |
8 |
|
coronavirus infections - veterinary - virology |
8 |
|
databases, nucleic acid - statistics & numerical data |
8 |
|
disease progression |
8 |
|
genes, viral - genetics |
8 |
|
history, 20th century |
8 |
|
hospitalization |
8 |
|
influenza a virus |
8 |
|
influenza a virus - classification - genetics - pathogenicity |
8 |
|
influenza a virus, h1n1 subtype - genetics |
8 |
|
influenza a virus, h5n1 subtype - isolation & purification - pathogenicity |
8 |
|
influenza a virus, h5n1 subtype - pathogenicity |
8 |
|
influenza, human - epidemiology - immunology |
8 |
|
influenza, human - immunology - virology |
8 |
|
innate host responses |
8 |
|
ip-10 |
8 |
|
mice |
8 |
|
nucleic acid amplification techniques - methods |
8 |
|
orthomyxoviridae infections - epidemiology - veterinary - virology |
8 |
|
orthomyxoviridae infections - transmission |
8 |
|
pandemic |
8 |
|
polymorphism, genetic |
8 |
|
positive selection |
8 |
|
poultry diseases - epidemiology - virology |
8 |
|
pregnancy |
8 |
|
pulmonary alveoli - immunology |
8 |
|
reassortant viruses - classification - genetics - isolation & purification |
8 |
|
respiratory mucosa - immunology - pathology |
8 |
|
reverse transcriptase polymerase chain reaction - methods |
8 |
|
rna, viral - analysis - genetics |
8 |
|
sequence homology |
8 |
|
severe acute respiratory syndrome - epidemiology - transmission - virology |
8 |
|
singapore - epidemiology |
8 |
|
swine diseases - epidemiology - transmission - virology |
8 |
|
swine influenza virus |
8 |
|
tropism |
8 |
|
viral proteins - chemistry - genetics |
8 |
|
5′-race assay |
7 |
|
antigenic variation |
7 |
|
antiviral agents - pharmacology |
7 |
|
antiviral agents - therapeutic use |
7 |
|
antiviral compounds |
7 |
|
astroviridae - classification - genetics - isolation and purification |
7 |
|
bird diseases - epidemiology - virology |
7 |
|
cell-mediated immunity |
7 |
|
child |
7 |
|
child, preschool |
7 |
|
chlorogenic acid - chemistry - pharmacology |
7 |
|
cluster analysis |
7 |
|
community-acquired-infections-epidemiology |
7 |
|
community-acquired-infections-mortality |
7 |
|
community-acquired-infections-physiopathology |
7 |
|
community-acquired-infections-virology |
7 |
|
coronavirus - classification - enzymology - genetics - isolation & purification |
7 |
|
coronavirus-genetics |
7 |
|
disease outbreaks - history |
7 |
|
disease reservoirs |
7 |
|
dna primers |
7 |
|
dna, viral - genetics |
7 |
|
dna-directed dna polymerase - genetics - metabolism |
7 |
|
drug synergism |
7 |
|
ecology |
7 |
|
epidemics |
7 |
|
etiology |
7 |
|
fatal outcome |
7 |
|
felidae - virology |
7 |
|
flavonoids - chemistry - pharmacology |
7 |
|
gene expression regulation |
7 |
|
gene expression regulation, viral - physiology |
7 |
|
genomic sequence |
7 |
|
glycyrrhizic acid - chemistry - pharmacology |
7 |
|
hemagglutination inhibition tests |
7 |
|
hemagglutinin glycoproteins, influenza virus - genetics - immunology |
7 |
|
hemagglutinin glycoproteins, influenza virus - metabolism |
7 |
|
hemagglutinins - genetics - metabolism |
7 |
|
highly pathogenic avian influenza |
7 |
|
infant |
7 |
|
influenza a virus - classification - genetics |
7 |
|
influenza a virus - classification - genetics - isolation & purification |
7 |
|
influenza a virus - genetics |
7 |
|
influenza a virus - isolation & purification |
7 |
|
influenza a virus, h1n1 subtype - enzymology - genetics - physiology |
7 |
|
influenza a virus, h5n1 subtype |
7 |
|
influenza a virus, h5n1 subtype - classification - genetics - isolation & purification - pathogenicity |
7 |
|
influenza a virus, h5n1 subtype - genetics |
7 |
|
influenza a virus, h5n1 subtype - genetics - isolation & purification |
7 |
|
influenza in birds - transmission - virology |
7 |
|
influenza, human - epidemiology - history |
7 |
|
interferon-alpha - pharmacology |
7 |
|
interferon-beta - pharmacology |
7 |
|
lopinavir |
7 |
|
lung - radiography |
7 |
|
membrane glycoproteins - genetics |
7 |
|
microbial sensitivity tests |
7 |
|
models, biological |
7 |
|
molecular clock |
7 |
|
mustelidae - virology |
7 |
|
nasopharynx - virology |
7 |
|
neuraminidase - metabolism |
7 |
|
nucleocapsid proteins - genetics |
7 |
|
orthomyxoviridae infections - epidemiology - transmission - virology |
7 |
|
pyrimidinones - pharmacology |
7 |
|
quail - virology |
7 |
|
reassortant |
7 |
|
ribavirin - pharmacology |
7 |
|
rimantadine - pharmacology |
7 |
|
rna helicases - genetics |
7 |
|
rna replicase - genetics |
7 |
|
rna, viral - analysis |
7 |
|
rodent diseases - virology |
7 |
|
sars cov |
7 |
|
sars virus - drug effects |
7 |
|
sars virus - genetics - immunology |
7 |
|
sensitivity and specificity |
7 |
|
severe acute respiratory syndrome - epidemiology - history - virology |
7 |
|
subgenomic transcripts |
7 |
|
swine diseases - virology |
7 |
|
universal vaccine |
7 |
|
vaccination - veterinary |
7 |
|
viral envelope proteins - genetics |
7 |
|
viral genes |
7 |
|
viral plaque assay |
7 |
|
virology - methods |
7 |
|
viverridae - virology |
7 |
|
adaptation |
6 |
|
administration, oral |
6 |
|
aerosols |
6 |
|
amantadine-pharmacology |
6 |
|
amoxicillin-potassium clavulanate combination - administration & dosage |
6 |
|
antigens, viral - genetics |
6 |
|
australasia - epidemiology |
6 |
|
biodiversity conservation |
6 |
|
biopsy |
6 |
|
bronchi - pathology |
6 |
|
carnivora - virology |
6 |
|
cats |
6 |
|
cattle |
6 |
|
cell nucleus - ultrastructure |
6 |
|
chickens - immunology |
6 |
|
conservation of natural resources |
6 |
|
coronaviridae - classification - genetics - isolation & purification - physiology |
6 |
|
coronaviridae infections - transmission - veterinary - virology |
6 |
|
coronavirus - classification - genetics - immunology - isolation & purification |
6 |
|
coronavirus - classification - isolation & purification - ultrastructure |
6 |
|
coronavirus 229e, human - immunology |
6 |
|
coronavirus infections |
6 |
|
coronavirus infections - diagnosis - transmission - virology |
6 |
|
coronavirus oc43, human - immunology |
6 |
|
cross infection - complications |
6 |
|
cytokine |
6 |
|
cytokines - biosynthesis - genetics |
6 |
|
cytokines - genetics - metabolism |
6 |
|
cytopathogenic effect, viral |
6 |
|
demography |
6 |
|
diagnosis, differential |
6 |
|
disease reservoirs - veterinary - virology |
6 |
|
disease reservoirs - virology |
6 |
|
dna, viral - classification - genetics |
6 |
|
drug resistance, viral |
6 |
|
drug-resistance,-viral-genetics |
6 |
|
ducks - genetics - virology |
6 |
|
ducks - immunology |
6 |
|
early diagnosis |
6 |
|
ecosystem |
6 |
|
europe - epidemiology |
6 |
|
far east - epidemiology |
6 |
|
ferrets |
6 |
|
fever - diagnosis |
6 |
|
follow-up studies |
6 |
|
fractional factorial design |
6 |
|
geese - immunology |
6 |
|
giant cells - ultrastructure |
6 |
|
guidelines as topic |
6 |
|
h7n9 |
6 |
|
hiv protease inhibitors - therapeutic use |
6 |
|
hospitalization - statistics and numerical data |
6 |
|
immunocompromised host - immunology |
6 |
|
influenza a virus - genetics - isolation & purification |
6 |
|
influenza a virus, h1n1 subtype - classification - genetics - isolation & purification - pathogenicity |
6 |
|
influenza a virus, h1n2 subtype - classification - genetics - isolation & purification |
6 |
|
influenza a virus, h3n2 subtype - genetics - pathogenicity |
6 |
|
influenza a virus, h3n2 subtype - genetics - physiology |
6 |
|
influenza a virus, h5n1 subtype - genetics - immunology - isolation & purification - pathogenicity |
6 |
|
influenza a virus, h5n1 subtype - immunology - isolation & purification |
6 |
|
influenza a virus, h9n2 subtype |
6 |
|
influenza a virus, h9n2 subtype - chemistry - classification |
6 |
|
influenza a virus, h9n2 subtype - genetics - immunology |
6 |
|
influenza a virus, h9n2 subtype - isolation & purification |
6 |
|
influenza in birds - diagnosis - genetics - virology |
6 |
|
influenza in birds - immunology - prevention & control |
6 |
|
influenza in birds - immunology - virology |
6 |
|
influenza polymerase |
6 |
|
influenza vaccines - administration & dosage |
6 |
|
influenza, human - complications - diagnosis - epidemiology |
6 |
|
influenza, human - complications - epidemiology |
6 |
|
influenza, human - diagnosis - genetics - virology |
6 |
|
influenza, human - epidemiology |
6 |
|
influenza, human - immunology |
6 |
|
influenza, human - metabolism - virology |
6 |
|
influenza, human - transmission |
6 |
|
influenza-a-virus,-h5n1-subtype-drug-effects |
6 |
|
influenza-a-virus,-h5n1-subtype-genetics |
6 |
|
influenzavirus a - genetics - immunology - pathogenicity |
6 |
|
infusions, intravenous |
6 |
|
length of stay |
6 |
|
lung - pathology - virology |
6 |
|
macrophages - immunology |
6 |
|
macrophages - immunology - virology |
6 |
|
membrane glycoproteins - chemistry - genetics |
6 |
|
metaplasia |
6 |
|
metapneumovirus - isolation & purification |
6 |
|
mice, inbred balb c |
6 |
|
microscopy, electron |
6 |
|
molecular diagnostic techniques - methods |
6 |
|
morbidity |
6 |
|
mutation |
6 |
|
mutation - genetics |
6 |
|
nasal cavity - virology |
6 |
|
new york - epidemiology |
6 |
|
nose - virology |
6 |
|
ofloxacin |
6 |
|
open reading frames - genetics |
6 |
|
opportunistic infections - diagnosis - transmission - virology |
6 |
|
organ size |
6 |
|
orthomyxoviridae - genetics - isolation & purification - pathogenicity |
6 |
|
orthomyxoviridae infections - transmission - veterinary - virology |
6 |
|
owston's civet |
6 |
|
paramyxoviridae infections - diagnosis - epidemiology - virology |
6 |
|
pharynx - virology |
6 |
|
phylogeography |
6 |
|
pneumonia - diagnosis - veterinary - virology |
6 |
|
population dynamics |
6 |
|
population surveillance |
6 |
|
poultry diseases - prevention & control |
6 |
|
pregnancy complications, infectious - diagnosis - therapy |
6 |
|
pulmonary alveoli - immunology - virology |
6 |
|
pulse therapy, drug |
6 |
|
pyrimidinones - therapeutic use |
6 |
|
quarantine - veterinary |
6 |
|
real time rt-pcr |
6 |
|
reassortant viruses - genetics - isolation & purification - pathogenicity |
6 |
|
rectum - virology |
6 |
|
regional index: china |
6 |
|
respiratory syncytial virus infections - diagnosis - epidemiology - virology |
6 |
|
respiratory syncytial viruses - isolation & purification |
6 |
|
respiratory tract infections |
6 |
|
respiratory tract infections - diagnosis - epidemiology - virology |
6 |
|
reverse transcriptase polymerase chain reaction - methods - standards |
6 |
|
rimantadine-pharmacology |
6 |
|
risk factors |
6 |
|
ritonavir - therapeutic use |
6 |
|
rna interference |
6 |
|
rna, messenger - analysis |
6 |
|
rna, viral |
6 |
|
rna, viral - analysis - isolation & purification |
6 |
|
rna, viral - genetics - isolation & purification |
6 |
|
sars coronavirus |
6 |
|
sars virus - classification - genetics - immunology - isolation & purification |
6 |
|
sars virus - genetics - immunology - isolation & purification |
6 |
|
sars virus - pathogenicity |
6 |
|
selection, genetic |
6 |
|
sequence deletion |
6 |
|
sequence homology, nucleic acid |
6 |
|
severe acute respiratory syndrome - blood - immunology |
6 |
|
severe acute respiratory syndrome - complications - pathology - virology |
6 |
|
severe acute respiratory syndrome - diagnosis - drug therapy - epidemiology - virology |
6 |
|
severe acute respiratory syndrome - diagnosis - immunology - virology |
6 |
|
severe acute respiratory syndrome - diagnosis - transmission - virology |
6 |
|
severe acute respiratory syndrome - diagnosis - virology |
6 |
|
severe acute respiratory syndrome - drug therapy - virology |
6 |
|
severe acute respiratory syndrome - epidemiology - microbiology |
6 |
|
severe acute respiratory syndrome - immunology - virology |
6 |
|
severity of illness index |
6 |
|
source-sink |
6 |
|
specimen handling |
6 |
|
surveillance |
6 |
|
survival rate |
6 |
|
tropical climate |
6 |
|
tumor necrosis factor-alpha - biosynthesis - genetics |
6 |
|
viral envelope proteins - chemistry - genetics |
6 |
|
viral load - statistics & numerical data |
6 |
|
viral proteins - genetics - metabolism |
6 |
|
virus cultivation |
6 |
|
viverrid |
6 |
|
viverridae - anatomy & histology - physiology - virology |
6 |
|
wild species infections |
6 |
|
zoonoses |
6 |
|
zoonoses - epidemiology |
6 |
|
actins - genetics |
5 |
|
administration, intranasal |
5 |
|
amino acid motifs |
5 |
|
animal migration |
5 |
|
antibodies, neutralizing - blood - immunology |
5 |
|
antibodies, viral - blood - immunology |
5 |
|
birds - physiology - virology |
5 |
|
calibration |
5 |
|
cell polarity |
5 |
|
chicken meat |
5 |
|
communicable diseases, emerging |
5 |
|
communicable diseases, emerging - epidemiology - immunology |
5 |
|
consensus primers |
5 |
|
consensus sequence |
5 |
|
coronavirus - classification - isolation and purification |
5 |
|
diagnostics |
5 |
|
diarrhea |
5 |
|
disease models, animal |
5 |
|
disease surveillance |
5 |
|
dna, complementary - analysis |
5 |
|
dna, protozoan - blood - genetics |
5 |
|
dna, ribosomal - analysis |
5 |
|
dna, viral - analysis - genetics |
5 |
|
dna, viral - chemistry - genetics |
5 |
|
endothelial cells - immunology - virology |
5 |
|
epithelial cells - immunology - virology |
5 |
|
feces analysis |
5 |
|
ferret |
5 |
|
gyrovirus |
5 |
|
h7n9 influenza virus |
5 |
|
haplorhini |
5 |
|
hemagglutinin glycoproteins, influenza virus - classification - genetics |
5 |
|
hot temperature |
5 |
|
hpai |
5 |
|
human infection |
5 |
|
immunity |
5 |
|
influenza a virus - classification - enzymology - genetics |
5 |
|
influenza a virus - classification - genetics - immunology - isolation and purification |
5 |
|
influenza a virus - classification - genetics - isolation and purification - pathogenicity |
5 |
|
influenza a virus - enzymology - genetics |
5 |
|
influenza a virus, h1n1 subtype - classification - genetics - isolation & purification |
5 |
|
influenza a virus, h1n1 subtype - classification - genetics - isolation and purification |
5 |
|
influenza a virus, h1n1 subtype - classification - immunology |
5 |
|
influenza a virus, h1n1 subtype - immunology - pathogenicity |
5 |
|
influenza a virus, h2n2 subtype - classification - genetics - isolation & purification |
5 |
|
influenza a virus, h3n2 subtype - classification - genetics - isolation & purification |
5 |
|
influenza a virus, h3n2 subtype - classification - genetics - isolation and purification |
5 |
|
influenza a virus, h9n2 subtype - classification - genetics - isolation & purification |
5 |
|
influenza a virus, h9n2 subtype - classification - genetics - isolation and purification |
5 |
|
influenza in birds - enzymology |
5 |
|
influenza in birds - epidemiology - genetics |
5 |
|
influenza virus a h9n2 |
5 |
|
interferon type i - pharmacology |
5 |
|
interferon-gamma - pharmacology |
5 |
|
lpai |
5 |
|
malaria, falciparum - blood - diagnosis |
5 |
|
mammals - virology |
5 |
|
methods |
5 |
|
molecular diagnostic techniques - economics - methods |
5 |
|
neuraminidase inhibitors |
5 |
|
open reading frames |
5 |
|
orthomyxoviridae infections - diagnosis - virology |
5 |
|
orthomyxoviridae infections - epidemiology - immunology |
5 |
|
orthomyxoviridae infections - transmission - virology |
5 |
|
pathogenicity |
5 |
|
plasmodium falciparum - genetics - isolation & purification |
5 |
|
polymerase chain reaction - economics - methods - standards |
5 |
|
polymerase chain reaction - methods |
5 |
|
polymerase genes |
5 |
|
quantitative rt-pcr |
5 |
|
r292k na mutation |
5 |
|
reassortant viruses - classification - genetics - isolation and purification - pathogenicity |
5 |
|
reference standards |
5 |
|
resistance |
5 |
|
reverse transcriptase polymerase chain reaction - economics - methods |
5 |
|
rna replicase - chemistry - genetics |
5 |
|
rna, ribosomal, 18s - genetics |
5 |
|
rna, viral - analysis - genetics - isolation & purification |
5 |
|
rna, viral - biosynthesis |
5 |
|
sars virus - genetics - growth & development - isolation & purification |
5 |
|
sars virus - metabolism - pathogenicity |
5 |
|
satellite tracking |
5 |
|
selection |
5 |
|
serial passage |
5 |
|
severe acute respiratory syndrome - diagnosis - epidemiology - prevention & control - transmission - virology |
5 |
|
specimen handling - methods |
5 |
|
swine diseases - epidemiology - virology |
5 |
|
transmission |
5 |
|
viral matrix proteins - genetics |
5 |
|
virus dna |
5 |
|
virus replication - drug effects |
5 |
|
wild birds |
5 |
|
animals, domestic - virology |
4 |
|
animals, wild |
4 |
|
antibodies, monoclonal - immunology |
4 |
|
antigen detection |
4 |
|
antigens, viral - analysis - immunology |
4 |
|
antigens, viral - classification - genetics - immunology |
4 |
|
asia |
4 |
|
asia, southeastern - epidemiology |
4 |
|
astrocytes - virology |
4 |
|
avian influenza a virus |
4 |
|
bioconductor |
4 |
|
biomarker |
4 |
|
bird diseases - epidemiology - transmission - virology |
4 |
|
bronchi - metabolism - virology |
4 |
|
charadriiformes - physiology - virology |
4 |
|
chemistry |
4 |
|
chickens |
4 |
|
chickens - virology |
4 |
|
cohort analysis |
4 |
|
coinfection - virology |
4 |
|
communicable disease control |
4 |
|
communicable diseases, emerging - epidemiology - history - virology |
4 |
|
communicable diseases, emerging - epidemiology - virology |
4 |
|
controlled study |
4 |
|
daily life activity |
4 |
|
data integration |
4 |
|
disease ecology |
4 |
|
dogs |
4 |
|
down-regulation |
4 |
|
epidemiological monitoring - veterinary |
4 |
|
europe |
4 |
|
fluorescent antibody technique |
4 |
|
geese - physiology - virology |
4 |
|
gene pool |
4 |
|
genome, viral - genetics |
4 |
|
h5n1 subtype |
4 |
|
hemagglutinins, viral - classification - genetics - immunology |
4 |
|
host-pathogen interactions - genetics - immunology |
4 |
|
immunoassay - methods |
4 |
|
immunohistochemistry |
4 |
|
infectious disease surveillance |
4 |
|
influenza a virus - classification - genetics - growth & development - isolation & |
4 |
|
influenza a virus - classification - isolation & purification - pathogenicity |
4 |
|
influenza a virus - genetics - isolation and purification |
4 |
|
influenza a virus - isolation and purification |
4 |
|
influenza a virus - physiology |
4 |
|
influenza a virus, h1n1 subtype - classification - genetics |
4 |
|
influenza a virus, h1n1 subtype - immunology - isolation and purification |
4 |
|
influenza a virus, h1n1 subtype - pathogenicity |
4 |
|
influenza a virus, h1n2 subtype - pathogenicity |
4 |
|
influenza a virus, h3n2 subtype - genetics |
4 |
|
influenza a virus, h5n1 subtype - genetics - immunology - isolation & purification |
4 |
|
influenza a virus, h5n1 subtype - genetics - pathogenicity |
4 |
|
influenza a virus, h5n1 subtype - genetics - physiology |
4 |
|
influenza a virus, h5n1 subtype - isolation and purification |
4 |
|
influenza a virus, h7n9 subtype - drug effects - genetics - isolation and purification |
4 |
|
influenza in birds - epidemiology - history - virology |
4 |
|
influenza in birds - epidemiology - transmission |
4 |
|
influenza vaccines |
4 |
|
influenza vaccines - genetics - immunology |
4 |
|
influenza, human - epidemiology - history - virology |
4 |
|
influenza, human - epidemiology - immunology - transmission |
4 |
|
influenza, human - epidemiology - transmission - veterinary - virology |
4 |
|
influenza, human - pathology - physiopathology - virology |
4 |
|
introns |
4 |
|
kuwait - epidemiology |
4 |
|
laos - epidemiology |
4 |
|
lysine - genetics |
4 |
|
macrophages - virology |
4 |
|
metagenomics |
4 |
|
migratory ducks |
4 |
|
molecular typing |
4 |
|
mutation, missense |
4 |
|
newcastle disease virus |
4 |
|
nonhuman |
4 |
|
nuclear factor 90 proteins - chemistry - genetics - metabolism |
4 |
|
nucleoproteins - genetics - metabolism |
4 |
|
orthomyxoviridae infections - veterinary - virology |
4 |
|
orthomyxoviridae infections - virology |
4 |
|
pandemic influenza |
4 |
|
pandemics - history |
4 |
|
pandemics control |
4 |
|
pb2 627 residue |
4 |
|
pholidota (animal) |
4 |
|
point mutation |
4 |
|
point-of care |
4 |
|
poultry diseases - virology |
4 |
|
prospective studies |
4 |
|
protein conformation |
4 |
|
reassortant viruses - classification - genetics |
4 |
|
reassortant viruses - genetics |
4 |
|
reassortant viruses - genetics - isolation and purification |
4 |
|
reassortant viruses - immunology - isolation and purification |
4 |
|
recombination, genetic |
4 |
|
reproducibility of results |
4 |
|
sars-cov-2 |
4 |
|
sentinel ducks |
4 |
|
severe acute respiratory syndrome - diagnosis |
4 |
|
sex difference |
4 |
|
state–space model |
4 |
|
survival |
4 |
|
temperature-sensitivity |
4 |
|
tissue tropism |
4 |
|
tumor necrosis factor-alpha - metabolism |
4 |
|
viral nonstructural proteins - genetics |
4 |
|
virulence - genetics |
4 |
|
virus interactions |
4 |
|
virus replication - genetics |
4 |
|
acetamides - therapeutic use |
3 |
|
age factors |
3 |
|
annotation |
3 |
|
antibodies, monoclonal - chemistry - immunology - isolation and purification |
3 |
|
antibodies, viral - biosynthesis - blood |
3 |
|
antibodies, viral - immunology |
3 |
|
antigenic drift |
3 |
|
antigenic variation - genetics |
3 |
|
antigenic variation - genetics - immunology |
3 |
|
antiviral agents - chemical synthesis |
3 |
|
antiviral agents - pharmacology - therapeutic use |
3 |
|
apoptosis |
3 |
|
ards |
3 |
|
avian influenza h5n1 |
3 |
|
avian influenza virus |
3 |
|
b-lymphocytes - immunology - virology |
3 |
|
bird diseases - physiopathology - transmission - virology |
3 |
|
bird diseases - virology |
3 |
|
body weight |
3 |
|
caliciviridae infections - virology |
3 |
|
capsid proteins - genetics |
3 |
|
cercopithecus aethiops |
3 |
|
chick embryo - virology |
3 |
|
clade 2.3.4.4 |
3 |
|
coinfection |
3 |
|
communicable diseases, emerging - mortality - transmission - virology |
3 |
|
communicable diseases, emerging - virology |
3 |
|
competition |
3 |
|
conserved sequence |
3 |
|
cross reactions - genetics |
3 |
|
cross-reactive |
3 |
|
culture media |
3 |
|
cytokines - blood - metabolism |
3 |
|
cytopathogenic effect, viral - physiology |
3 |
|
disease outbreaks - prevention & control - veterinary |
3 |
|
dna barcoding |
3 |
|
ducks |
3 |
|
efficacy of controls |
3 |
|
environmental transmission |
3 |
|
enzyme-linked immunosorbent assay - methods |
3 |
|
epidemiology |
3 |
|
epitopes - immunology |
3 |
|
eurasian gene pool |
3 |
|
flow cytometry |
3 |
|
food microbiology |
3 |
|
forecasting |
3 |
|
gastroenteritis - virology |
3 |
|
gene flow |
3 |
|
gene therapy |
3 |
|
genomic analysis |
3 |
|
ggtree |
3 |
|
h3n8 |
3 |
|
h5n8 |
3 |
|
hemagglutinin |
3 |
|
hemagglutinin glycoproteins, influenza virus - chemistry - genetics |
3 |
|
host specificity |
3 |
|
immune response |
3 |
|
immunization, passive |
3 |
|
immunodynamics |
3 |
|
immunoglobulin g - blood |
3 |
|
immunoglobulin m - blood |
3 |
|
immunoglobulin m - immunology |
3 |
|
immunologic memory - immunology |
3 |
|
inactivated vaccine |
3 |
|
incidence |
3 |
|
infection |
3 |
|
infectivity |
3 |
|
influenza a virus - pathogenicity |
3 |
|
influenza a virus, h1n1 subtype - genetics - isolation and purification - pathogenicity |
3 |
|
influenza a virus, h5n1 subtype - classification - genetics - immunology - isolation & purification |
3 |
|
influenza a virus, h5n1 subtype - genetics - immunology - pathogenicity - physiology |
3 |
|
influenza a virus, h7n7 subtype - classification - genetics |
3 |
|
influenza a virus, h9n2 subtype - immunology |
3 |
|
influenza antibody levels (流感抗體水平) |
3 |
|
influenza in birds - classification |
3 |
|
influenza in birds - epidemiology - prevention & control - transmission - virology |
3 |
|
influenza in birds - genetics |
3 |
|
influenza in birds - immunology |
3 |
|
influenza in birds - immunology - prevention and control - virology |
3 |
|
influenza vaccines - immunology |
3 |
|
influenza vaccines - immunology - supply & distribution |
3 |
|
influenza vaccines - therapeutic use |
3 |
|
influenza, human - blood - mortality - virology |
3 |
|
influenza, human - classification |
3 |
|
influenza, human - drug therapy - epidemiology - prevention & control - transmission |
3 |
|
influenza, human - drug therapy - virology |
3 |
|
influenza, human - epidemiology - therapy |
3 |
|
influenza, human - immunology - mortality - pathology |
3 |
|
influenza, human - mortality - pathology - virology |
3 |
|
injections, intramuscular |
3 |
|
intranasal immunization |
3 |
|
live bird market |
3 |
|
live poultry markets |
3 |
|
live-bird markets |
3 |
|
livestock - virology |
3 |
|
lung - immunology - metabolism |
3 |
|
macaca mulatta |
3 |
|
medical sciences |
3 |
|
migratory bird |
3 |
|
neuraminidase - antagonists & inhibitors - genetics |
3 |
|
neutralization test |
3 |
|
nomenclature |
3 |
|
norovirus - genetics |
3 |
|
north america |
3 |
|
novel |
3 |
|
orthomyxoviridae - drug effects - immunology - pathogenicity |
3 |
|
orthomyxoviridae - genetics - isolation and purification - pathogenicity |
3 |
|
orthomyxoviridae - pathogenicity |
3 |
|
orthomyxoviridae infections - pathology - transmission - veterinary |
3 |
|
oseltamivir |
3 |
|
oseltamivir - therapeutic use |
3 |
|
pandemic influenza a virus |
3 |
|
pandemics - prevention and control |
3 |
|
phylodynamics |
3 |
|
phylogenetics |
3 |
|
pneumonia, viral - radiography - virology |
3 |
|
predictive value of tests |
3 |
|
protection |
3 |
|
r package |
3 |
|
reassortant viruses - genetics - isolation and purification - pathogenicity |
3 |
|
reassortment |
3 |
|
receptors, virus - chemistry - metabolism |
3 |
|
respiration, artificial |
3 |
|
respiratory disease |
3 |
|
respiratory mucosa - cytology - metabolism |
3 |
|
restaurants |
3 |
|
risk |
3 |
|
risk assessment |
3 |
|
rna virus |
3 |
|
rna, small interfering - chemical synthesis - genetics |
3 |
|
rna, viral - antagonists & inhibitors - biosynthesis |
3 |
|
rural and urban households (社區人群) |
3 |
|
sars virus - genetics - isolation & purification - physiology |
3 |
|
sars-cov |
3 |
|
saα2,3gal linkage |
3 |
|
saα2,6gal linkage |
3 |
|
serology |
3 |
|
severe acute respiratory syndrome - blood - epidemiology - transmission - virology |
3 |
|
severe acute respiratory syndrome - diagnosis - epidemiology - prevention & control |
3 |
|
severe acute respiratory syndrome - epidemiology - immunology - prevention & control |
3 |
|
sialic acid receptors |
3 |
|
sialoglycoproteins - chemistry - metabolism |
3 |
|
social contact (人際接觸) |
3 |
|
swine diseases - pathology - virology |
3 |
|
t-lymphocytes - metabolism |
3 |
|
terminology as topic |
3 |
|
trachea - virology |
3 |
|
transfection |
3 |
|
transmissibility |
3 |
|
treatment outcome |
3 |
|
universal |
3 |
|
vaccination |
3 |
|
vaccination - statistics & numerical data |
3 |
|
vaccine |
3 |
|
vaccines |
3 |
|
vaccines, inactivated - administration & dosage |
3 |
|
vaccines, inactivated - administration & dosage - immunology |
3 |
|
vero cells |
3 |
|
viral evolution |
3 |
|
viral load |
3 |
|
viral vaccines - administration & dosage - immunology |
3 |
|
viral vaccines - administration & dosage - immunology - pharmacology |
3 |
|
virosphere |
3 |
|
visualization |
3 |
|
wholesale markets |
3 |
|
world health |
3 |
|
acute respiratory distress syndrome |
2 |
|
adamantane - therapeutic use |
2 |
|
adaptation, physiological |
2 |
|
amantadine |
2 |
|
anti-h5 monoclonal antibody |
2 |
|
antibodies, viral - genetics - immunology - metabolism |
2 |
|
antibody response |
2 |
|
antibody specificity - immunology |
2 |
|
antigenic cluster |
2 |
|
antigenic dendrogram |
2 |
|
antigenicity |
2 |
|
antigens, viral - chemistry - immunology |
2 |
|
antigens, viral - genetics - immunology |
2 |
|
antigens, viral - immunology |
2 |
|
aquatic poultry |
2 |
|
avian influenza virus h5n1 |
2 |
|
avian metapneumovirus |
2 |
|
biomedical research |
2 |
|
biomimetic nanocarrier |
2 |
|
biosafety |
2 |
|
bird diseases - transmission - virology |
2 |
|
butyrate |
2 |
|
cell line, tumor |
2 |
|
cell membrane vesicles |
2 |
|
central nervous system viral diseases - pathology - physiopathology - virology |
2 |
|
chick embryo |
2 |
|
chicken anemia virus |
2 |
|
chicken anemia virus - classification - genetics |
2 |
|
circoviridae infections - epidemiology - veterinary - virology |
2 |
|
clinical severity |
2 |
|
co-infection |
2 |
|
commerce |
2 |
|
contact diary |
2 |
|
critical community size |
2 |
|
cross-protection |
2 |
|
cross-variant neutralization |
2 |
|
disease control |
2 |
|
disease outbreaks - veterinary |
2 |
|
disease transmission |
2 |
|
disease vectors |
2 |
|
dissemination |
2 |
|
dna primers - genetics |
2 |
|
dot elisa |
2 |
|
dot-elisa |
2 |
|
duck |
2 |
|
efficacy |
2 |
|
elderly |
2 |
|
electrophoresis, polyacrylamide gel |
2 |
|
emerging infections |
2 |
|
endogenous type i interferon |
2 |
|
follow-up |
2 |
|
geese |
2 |
|
geese - virology |
2 |
|
gene expression |
2 |
|
genome organization |
2 |
|
genomics |
2 |
|
golden hamster |
2 |
|
h5 influenza virus |
2 |
|
h5n1 avian influenza virus |
2 |
|
h5n1 influenza virus |
2 |
|
h7n9 virus |
2 |
|
haemagglutination |
2 |
|
hemagglutination inhibition test |
2 |
|
hemagglutinins, viral - chemistry - genetics - immunology |
2 |
|
hemagglution inhibition |
2 |
|
hepatitis virus |
2 |
|
hepatocellular carcinoma |
2 |
|
hierarchical clustering |
2 |
|
high pathogenic avian influenza virus |
2 |
|
high-pathogenicity avian influenza |
2 |
|
highly pathogenic coronavirus |
2 |
|
homologous and heterologous rechallenge |
2 |
|
host |
2 |
|
human case |
2 |
|
human influenza h7n9 |
2 |
|
human lung |
2 |
|
humanized mouse model |
2 |
|
imbalanced innate immune responses |
2 |
|
immunoassay - veterinary |
2 |
|
immunoenzyme techniques - veterinary |
2 |
|
immunogenicity |
2 |
|
immunology |
2 |
|
immunopathogenesis |
2 |
|
infectious |
2 |
|
infectious disease transmission |
2 |
|
influenza a virus - chemistry - classification - genetics - pathogenicity |
2 |
|
influenza a virus - classification - enzymology - genetics - immunology |
2 |
|
influenza a virus - classification - genetics - immunology - pathogenicity |
2 |
|
influenza a virus - classification - isolation and purification |
2 |
|
influenza a virus - drug effects - immunology |
2 |
|
influenza a virus - genetics - physiology |
2 |
|
influenza a virus - isolation & purification - pathogenicity - physiology |
2 |
|
influenza a virus - pathogenicity - physiology |
2 |
|
influenza a virus, h1n1 subtype - genetics - immunology - physiology |
2 |
|
influenza a virus, h3n2 subtype |
2 |
|
influenza a virus, h5n1 subtype - classification - drug effects - genetics |
2 |
|
influenza a virus, h5n1 subtype - classification - genetics - immunology |
2 |
|
influenza a virus, h5n1 subtype - classification - genetics - pathogenicity |
2 |
|
influenza a virus, h5n1 subtype - classification - immunology |
2 |
|
influenza a virus, h5n1 subtype - growth & development - immunology - pathogenicity |
2 |
|
influenza a virus, h5n1 subtype - immunology - isolation and purification |
2 |
|
influenza a virus, h5n1 subtype - isolation and purification - pathogenicity |
2 |
|
influenza a(h7n9) |
2 |
|
influenza a/h7n9 |
2 |
|
influenza h7n9 |
2 |
|
influenza h7n9 virus |
2 |
|
influenza in birds - diagnosis |
2 |
|
influenza in birds - diagnosis - virology |
2 |
|
influenza in birds - epidemiology - immunology - transmission |
2 |
|
influenza vaccines - administration and dosage - genetics - immunology |
2 |
|
influenza, human - drug therapy - epidemiology - virology |
2 |
|
influenza, human - drug therapy - prevention & control |
2 |
|
influenza, human - epidemiology - immunology - prevention and control |
2 |
|
influenza, human - epidemiology - transmission |
2 |
|
influenza, human - epidemiology - veterinary - virology |
2 |
|
influenza, human - immunology - prevention and control - virology |
2 |
|
interferon |
2 |
|
interferon-alpha - administration and dosage - immunology |
2 |
|
jingmen tick virus |
2 |
|
laboratory diagnosis |
2 |
|
lineages |
2 |
|
live birds markets |
2 |
|
mass spectrometric sequencing |
2 |
|
mathematical modelling |
2 |
|
metapneumovirus - classification - genetics |
2 |
|
microneutralization test |
2 |
|
mixed infection |
2 |
|
molecular |
2 |
|
molecular evolution |
2 |
|
monoclonal antibody |
2 |
|
neuraminidase - antagonists & inhibitors |
2 |
|
neuraminidase - genetics - immunology |
2 |
|
neuraminidase - immunology |
2 |
|
neuraminidase inhibitor |
2 |
|
nidovirus |
2 |
|
nigeria |
2 |
|
non-human primates |
2 |
|
nucleoprotein |
2 |
|
oligodeoxyribonucleotides - administration and dosage - immunology |
2 |
|
omicron |
2 |
|
oncolytic effectiveness |
2 |
|
orthomyxoviridae infections - diagnosis - immunology - virology |
2 |
|
orthomyxoviridae infections - epidemiology - immunology - prevention and control |
2 |
|
orthomyxovirus |
2 |
|
outbreak |
2 |
|
oxidative stress |
2 |
|
pandemic potential |
2 |
|
paramyxoviridae infections - veterinary |
2 |
|
peptide mimic |
2 |
|
phenotype |
2 |
|
phylogenetic tree |
2 |
|
pigeons |
2 |
|
pneumonia |
2 |
|
point of care |
2 |
|
polymorphism of viral antigen |
2 |
|
poultry diseases - diagnosis - virology |
2 |
|
poultry markets |
2 |
|
prime-boost |
2 |
|
proteins - genetics - metabolism |
2 |
|
quail |
2 |
|
r0 |
2 |
|
rapid test |
2 |
|
reassortant viruses - immunology |
2 |
|
receptor |
2 |
|
receptors, virus - metabolism |
2 |
|
recombinant fowl pox |
2 |
|
recombinant proteins - immunology - metabolism |
2 |
|
replicase |
2 |
|
replication and transcription |
2 |
|
ressortment |
2 |
|
reverse genetics |
2 |
|
reverse transcriptase polymerase chain reaction - veterinary |
2 |
|
rna processing |
2 |
|
roc curve |
2 |
|
sequence analysis, dna - veterinary |
2 |
|
severe disease |
2 |
|
single-chain antibodies - genetics - immunology - metabolism |
2 |
|
single-chain fragment |
2 |
|
social mixing |
2 |
|
stochastic model |
2 |
|
subgenomic mrna synthesis |
2 |
|
swine diseases - diagnosis - immunology - virology |
2 |
|
ticks |
2 |
|
transcription, genetic |
2 |
|
travel |
2 |
|
turkeys |
2 |
|
type i ifn |
2 |
|
type i interferon |
2 |
|
vaccine and drug discovery |
2 |
|
vaccines, synthetic - immunology |
2 |
|
waterfowl |
2 |
|
xenograft |
2 |
|
zanamivir |
2 |
|
3c proteinase |
1 |
|
acute respiratory syndrome |
1 |
|
adoptive transfer |
1 |
|
algorithms |
1 |
|
angiotensin-converting enzyme 2 |
1 |
|
anti-inflammation |
1 |
|
antibodies, monoclonal |
1 |
|
antigen test |
1 |
|
apoptosis - genetics |
1 |
|
autophagy |
1 |
|
bird diseases - epidemiology - transmission |
1 |
|
bivalent vaccine |
1 |
|
bronchi - immunology - pathology - virology |
1 |
|
bronchial epithelial cells |
1 |
|
car-t |
1 |
|
carrier state |
1 |
|
carrier state - virology |
1 |
|
cd8-positive t-lymphocytes - immunology |
1 |
|
chiroptera - genetics - virology |
1 |
|
cloaca - virology |
1 |
|
clodronic acid - pharmacology |
1 |
|
composition vector |
1 |
|
covid-19 |
1 |
|
cysteine protease |
1 |
|
cytochromes b - genetics |
1 |
|
cytokines |
1 |
|
drug design |
1 |
|
drug design and development |
1 |
|
drug interaction |
1 |
|
elisa |
1 |
|
enterovirus 71 |
1 |
|
epithelial cells - immunology - pathology - virology |
1 |
|
gene amplification |
1 |
|
gene expression regulation - immunology |
1 |
|
gene signature |
1 |
|
genetic reassortment |
1 |
|
genotyping |
1 |
|
h5n1 avian influenza |
1 |
|
h9n2 |
1 |
|
hand, foot and mouth disease |
1 |
|
horse diseases - epidemiology - virology |
1 |
|
horses |
1 |
|
host range |
1 |
|
host responses |
1 |
|
host-pathogen interactions - genetics |
1 |
|
immunity, innate - genetics |
1 |
|
immunochromatographic test |
1 |
|
influenza a virus - chemistry - classification - genetics - immunology |
1 |
|
influenza a virus - classification - isolation & purification - physiology - ultrastructure |
1 |
|
influenza a virus, h1n1 subtype |
1 |
|
influenza a virus, h1n1 subtype - genetics - immunology - pathogenicity |
1 |
|
influenza a virus, h5n1 subtype - genetics - isolation and purification - pathogenicity |
1 |
|
influenza a virus, h9n2 subtype - genetics - immunology - pathogenicity |
1 |
|
influenza a virus, h9n2 subtype - growth and development - pathogenicity |
1 |
|
influenza in birds - immunology - prevention and control |
1 |
|
influenza reassortment |
1 |
|
influenza vaccines - administration and dosage - immunology |
1 |
|
influenza, human - immunology - prevention and control |
1 |
|
influenza, human - immunology - therapy - virology |
1 |
|
interleukin-10 - genetics |
1 |
|
interspecies transmission |
1 |
|
korea |
1 |
|
lung diseases - immunology - virology |
1 |
|
macrophages, alveolar - drug effects - immunology |
1 |
|
middle eastern respiratory syndrome coronavirus |
1 |
|
nf-κb pathway |
1 |
|
nomogram |
1 |
|
nucleic acid amplification techniques |
1 |
|
oligonucleotides |
1 |
|
orthomyxoviridae - immunology |
1 |
|
orthomyxoviridae infections - epidemiology - veterinary |
1 |
|
orthomyxoviridae infections - immunology |
1 |
|
orthomyxoviridae infections - immunology - prevention and control |
1 |
|
peptidomimetics |
1 |
|
phylogenetic analysis |
1 |
|
poultry - immunology - virology |
1 |
|
prognostic model |
1 |
|
rats |
1 |
|
rupintrivir |
1 |
|
sars virus - classification - genetics - isolation & purification |
1 |
|
software |
1 |
|
tcga |
1 |
|
tumor necrosis factor-alpha - genetics |
1 |
|
turkeys - virology |
1 |
|
viral adaptation |
1 |
|
virus infection |
1 |
|
virus shedding |
1 |
|
wilms tumor |
1 |
|
zoonoses - virology |
1 |
